Evidence map›Paper›PMID 35926881›Full record

ArticleGenes & development2022

Yeast ORC sumoylation status fine-tunes origin licensing.

Gemma Regan-Mochrie, Timothy Hoggard, Nikhil Bhagwat, Gerard Lynch, Neil Hunter, Dirk Remus, Catherine A Fox, Xiaolan Zhao

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Multifaceted roles of SUMO in DNA metabolism.Nucleus (Austin, Tex.) · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Ubiquitin and SUMO pathways in DNA replication and replication-coupled repair.Critical reviews in biochemistry and molecular biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Gemma Regan-MochrieMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Timothy HoggardDepartment of Biomolecular Chemistry, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin 53706, USA.ORCID http://orcid.org/0000-0003-0589-1271
Nikhil BhagwatHoward Hughes Medical Institute, University of California at Davis, Davis, California 95616, USA.ORCID http://orcid.org/0000-0002-2945-6453
Gerard LynchMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Neil HunterHoward Hughes Medical Institute, University of California at Davis, Davis, California 95616, USA.ORCID http://orcid.org/0000-0003-1498-2327
Dirk RemusMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Catherine A FoxDepartment of Biomolecular Chemistry, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin 53706, USA.
Xiaolan ZhaoMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.ORCID http://orcid.org/0000-0002-8302-6905
Memorial Sloan Kettering Cancer Center · USHoward Hughes Medical Institute · USUniversity of Wisconsin–Madison · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Joint Molecule Resolution During Meiotic RecombinationR01GM074223 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI HUNTER, NEIL · 2005 to 2025
$6.0M
Mechanism of DNA replication initiation in Saccharomyces cerevisiaeR01GM107239 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI REMUS, DIRK · 2014 to 2023
$3.9M
Regulation of genome replication, recombination, and stress responseR35GM145260 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI Xiaolan Zhao · 2022 to 2026
$3.6M
NIGMS Research Undergraduate Supplement for R35GM141641R35GM141641 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, CATHERINE A · 2021 to 2025
$2.2M
Regulation of Replication and Recombination IntermediatesR01GM131058 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI ZHAO, XIAOLAN · 2019 to 2022
$1.6M
NCI NIH HHS P30 CA008748NIGMS NIH HHS R01 GM074223NIGMS NIH HHS R01 GM107239NIGMS NIH HHS R01 GM131058NIGMS NIH HHS R35 GM141641NIGMS NIH HHS R35 GM145260
6 · The paper itself

Abstract

Sumoylation is emerging as a posttranslation modification important for regulating chromosome duplication and stability. The origin recognition complex (ORC) that directs DNA replication initiation by loading the MCM replicative helicase onto origins is sumoylated in both yeast and human cells. However, the biological consequences of ORC sumoylation are unclear. Here we report the effects of hypersumoylation and hyposumoylation of yeast ORC on ORC activity and origin function using multiple approaches. ORC hypersumoylation preferentially reduced the function of a subset of early origins, while Orc2 hyposumoylation had an opposing effect. Mechanistically, ORC hypersumoylation reduced MCM loading in vitro and diminished MCM chromatin association in vivo. Either hypersumoylation or hyposumoylation of ORC resulted in genome instability and the dependence of yeast on other genome maintenance factors, providing evidence that appropriate ORC sumoylation levels are important for cell fitness. Thus, yeast ORC sumoylation status must be properly controlled to achieve optimal origin function across the genome and genome stability.

Indexed as

MCMORCreplication initiationreplication regulationsumoylation

Identifiers

PMID35926881
PMCPMC9480853
OpenAlexW4289846637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.